Skip to main content

Triamcinolone Hexacetonide Injection

Last Updated: October 11, 2022
Status: Current

Reason for the Shortage
    • Sandoz discontinued Aristospan in September 2020.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Medexus in conjunction with FDA has initiated a temporary importation of Triamcinolone Hexacetonide (Hexatrione 2%) injectable suspension 20 mg/mL 2 mL ampules (NDC 59137-0570-01), to the U.S. market to address drug shortage. To place an order, please contact ANDA at1-855-336-3322, Option # 9. There is a side by side comparison between Aristospan and Hexatrione available at https://www.fda.gov/media/154709/download.

Updated

Updated October 11, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 22, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer